In GBM cells, upregulation of praja2 stimulates the mitogenic cascade, inhibits oncosuppressive pathways and promotes the metabolic rewiring underlying tumor growth (Lignitto et al, 2013; Delle Donne et al, 2022). This evidence concerns the gene PJA2 and neoplasm.